Multiple Myeloma
Showing NaN - NaN of 67
Presentation, Treatment Patterns, and Outcomes in Multiple
Completed
- Multiple Myeloma
- No Intervention
-
Little Rock, Arkansas
- +136 more
Feb 15, 2022
Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)
Completed
- Multiple Myeloma
-
Graz, Austria
- +111 more
Dec 10, 2021
Multiple Myeloma Trial in Austria, Germany (MOR03087 phase 1 dose escalation, MOR03087, Dexamethasone)
Completed
- Multiple Myeloma
- MOR03087 phase 1 dose escalation
- +4 more
-
Vienna, Austria
- +9 more
Nov 12, 2021
Relapsed or Refractory Haematological Malignancies Including, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in
Completed
- Relapsed or Refractory Haematological Malignancies Including
- +10 more
-
Aachen, Germany
- +11 more
Oct 21, 2021
Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)
Completed
- Multiple Myeloma
- HLA Matched allogeneic transplant
-
Wien, Austria
- +23 more
Oct 5, 2021
Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Durvalumab
- +2 more
-
Little Rock, Arkansas
- +34 more
Aug 4, 2021
Multiple Myeloma Trial in Germany (Bendamustine, Bortezomib, Prednisone)
Completed
- Multiple Myeloma
- Bendamustine, Bortezomib, Prednisone
-
Mannheim, Ba-Wü, Germany
- +14 more
Oct 14, 2020